Travel pass: Pros may outweigh cons
IATA’s mobile application will allow travellers to store and manage certifications for Covid-19 tests or ...
Hospitals have attempted to put their best foot forward in accepting the Government’s price-cap on Covid-19 vaccines. The challenge, though, could emerge in handling side-effects or complications that arise after the vaccination, say doctors and industry insiders. The Government had capped the price at ₹250, which included ₹150 for the vaccine and ₹100 to the hospital for administration.
Raman Bhaskar, Hospital Director at HCMCT - Manipal Hospitals, said that hospitals were going with the price-cap as it was a “pandemic service”. The challenge could emerge if a patient has a reaction that the individual believes is linked to the vaccination and requires hospitalisation. Protocols have been laid out and hospitals have been asked to connect with a nodal officer who would then direct the person with the reaction to a nodal hospital, Bhaskar told BusinessLine. The challenge emerges given the vulnerable population and elderly that are being vaccinated and when the number begins to increase, he said.
Under the present system, the supplies are controlled and monitored, with hospitals procuring the vaccines from the Government and not directly from the vaccine companies. Across the country, hospital top-brass were seen to be accepting of the price-cap, bracing for the challenges that unfold in the event of vaccine-linked reactions.
Dr Adbul Ghafur, infectious diseases consultant with Apollo Cancer Institute, was optimistic that systems were in place across the country to vaccinate and observe people thereafter. On the price-caps, he said, it would have come about only after discussion. Private vaccine companies would be able to get marginal profits, he added. For those seeking free vaccines, there are Government centres.
On the vaccine companies side, Serum Institute of India and Bharat Biotech, whose vaccines are being rolled out, have maintained a studied public silence on pricing.
IATA’s mobile application will allow travellers to store and manage certifications for Covid-19 tests or ...
A 2010 Act to regulate the medical sector flounders in implementation, even as healthcare remains ...
The scheme to boost local medtech manufacturing is timely, especially given the raging pandemic. But ...
Do pilots sleep on their job?
Fiscal stimulus, friendly monetary policy and firm commodity prices point towards normalcy, says the MD and ...
Price correction is a good opportunity for long-term investors to take the plunge
Q4 earnings, along with progress in controlling Covid-19 spread, will be in focus
Do keep in mind that premium may go up in case one of the members has a pre-existing condition
In an age of falling female workforce participation, worsened by the Covid-19 pandemic, policy makers and ...
Of an injured baby goat, young men on motorcycles and political tensions
It’s the birthday of Muttiah Muralitharan — the man who took a staggering 800 test wickets. What better way to ...
An ode to writer and great-uncle Ved Mehta, and Ekarat, the friend who wrote and quit on his own terms
Monotype’s 2021 type trends report points to a return to hand and the familiar
As ‘ear-points’ between a company and a customer grow, we are witnessing a rise in audio assets
‘Desi Twitter challenger’ Koo on connecting like-minded folks
Coca-Cola has just introduced an oat milk line in the US under its Simply brand. Smart move, say industry ...
Three years after its inception, compliance with GST procedures remains a headache for exporters, job workers ...
Corporate social responsibility (CSR) initiatives of companies are altering the prospects for wooden toys of ...
Aequs Aerospace to create space for large-scale manufacture of toys at Koppal
And it has every reason to smile. Covid-19 has triggered a consumer shift towards branded products as ...
Please Email the Editor